Abstract:Background: Colon cancer is one of the most prevalent digestive cancers worldwide. Results of epidemiological, experimental, and clinical studies suggest that aspirin inhibits the development of colon cancer. This study aimed to systematically elucidate the molecular mechanisms by which aspirin prevents colon carcinogenesis. Methods: We determined the global protein expression profiles of colorectal cancer and aspirin-treated cells using quantitative proteomic analysis. We analyzed the proteomic results using bioinformatics (including differential proteins, protein annotation, Kyoto Encyclopedia of Genes and Genomes [KEGG] pathways, and protein-protein interaction [PPI] network). The viability of the colon cancer cell line and HT29 cells treated with aspirin was determined using the cell counting kit-8 assay. The differentially expressed proteins, such as p53 and cyclin-dependent kinase 1 (CDK1), were quantified using real-time polymerase chain reaction (PCR) and Western blotting. We measured cell cycle distribution and apoptosis in HT29 cells exposed to aspirin using fluorescence-activated cell sorting (FACS). Results: We found that 552 proteins were significantly dysregulated, of which 208 and 334 were upregulated and downregulated, respectively, in colon cancer cells exposed to 10 mmol/L of aspirin (95% confidence interval [CI]: -1.269 to -0.106, P < 0.05). Further gene enrichment analysis revealed that cell cycle-related proteins, such as p53 and CDK1, were significantly differentially expressed. Proteomic analysis showed that after 24 h of aspirin exposure, the level of p53 increased by 2.52-fold and CDK1 was downregulated to half that of the controls in HT29 cells (95% CI: -0.619 to -0.364, P < 0.05). Real-time PCR and Western blotting results showed that p53 was upregulated (95%CI: -3.088 to -1.912, P < 0.001) and CDK1 was significantly downregulated after aspirin exposure in colon cancer cells (95% CI: 0.576 to 1.045, P < 0.05). We observed that aspirin promoted G1/S cell cycle arrest in HT29 cells. We confirmed that aspirin induces apoptosis in human HT29 colon cancer cells in a concentration-dependent manner. Conclusions: These results indicate that aspirin induces G1 arrest and apoptosis in colorectal cancer cells via the p53-CDK1 pathway. Aspirin may be a promising drug candidate for colon cancer prevention.

Activation of the Caspase-8/Bid and Bax Pathways in Aspirin-Induced Apoptosis in Gastric Cancer.

The Inhibiting Effect of Combination of Allicin with Paclitaxel on Proliferation of Gastric Cancer Cells and Promotion of Apoptosis

Apoptosis of SGC7901 Gastric Cancer Cell Induced by Cyanidin-3-glucoside

Cyclooxygenase-Independent Effects of Aspirin on Ht-29 Human Colon Cancer Cells, Revealed by Oligonucleotide Microarrays

Significance of Expression of Bcl-2 Mrna and Bax Mrna in Arsenic Trioxide-Induced Apoptosis of Hepatocellular Carcinoma Cells

Role Of P38 Mapk In Enhanced Human Cancer Cells Killing By The Combination Of Aspirin And Abt-737

Aspirin‐induced activation of the NF‐κB signaling pathway: a novel mechanism for aspirin‐mediated apoptosis in colon cancer cells

Astragalus Extract Inhibits Proliferation but Enhances Apoptosis in Gastric Cancer.

Effect and Possible Mechanism of Aspirin on Cell Growth and Occludin Expression in Human Gastric Mucosal Epithelial Cells

Mechanisms Underlying Apoptosis of Gastric Cancer Cell Line Induced by Combination of 5-Fluorouracil and Matrine

AMPK Activator AICAR Promotes 5-Fu-induced Apoptosis in Gastric Cancer Cells

Aspirin Potentiates Celecoxib-Induced Growth Inhibition and Apoptosis in Human Non-Small Cell Lung Cancer by Targeting GRP78 Activity.

Esculetin Induces Apoptosis in Human Gastric Cancer Cells Through a Cyclophilin D-mediated Mitochondrial Permeability Transition Pore Associated with ROS.

Acetyl-11-keto-β-boswellic acid inhibits proliferation and induces apoptosis of gastric cancer cells through the phosphatase and tensin homolog /Akt/ cyclooxygenase-2 signaling pathway

Effects of aspirin on colon cancer using quantitative proteomic analysis

PI3K/Akt is Involved in Bufalin-Induced Apoptosis in Gastric Cancer Cells

Preparation of novel anthraquinone-based aspirin derivatives with anti-cancer activity

Study on Action Mechanisms for the Effect of Pseudolaric Acid B in Inducing Apoptosis of Human Gastric Carcinoma Cell Line AGS

Aspirin Inhibits Colorectal Cancer via the TIGIT-BCL2-BAX pathway in T Cells

Activation of P53 Signalling in Acetylsalicylic Acid-Induced Apoptosis in Oc2 Human Oral Cancer Cells

Aspirin Cooperates with P300 to Activate the Acetylation of H3K9 and Promote FasL-mediated Apoptosis of Cancer Stem-Like Cells in Colorectal Cancer